Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

53 Résultats
authIdHal_s : fanny-baran-marszak

Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma

F. Baran-Marszak , M. Boukhiar , S. Harel , C. Laguillier , C. Roger et al.
Haematologica, 2010, 95 (11), pp.1865-1872. ⟨10.3324/haematol.2009.019745⟩
Article dans une revue hal-03945121v1

Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

Larry Mansouri , Birna Thorvaldsdottir , Lesley-Ann Sutton , Georgios Karakatsoulis , Manja Meggendorfer et al.
Article dans une revue hal-03942448v1

Different Prognostic Impact of Recurrent Gene Mutations in IGHV-Mutated and IGHV-Unmutated Chronic Lymphocytic Leukemia: A Retrospective, Multi-Center Cohort Study By Eric, the European Research Initiative on CLL, in Harmony

Larry Mansouri , Birna Thorvaldsdottir , Lesley-Ann Sutton , Manja Meggendorfer , Ferran Nadeu et al.
ASH, Dec 2021, Atlanta, United States. pp.2617-2617, ⟨10.1182/blood-2021-150648⟩
Communication dans un congrès inserm-03950165v1

Prevalence, distribution and predictive value of XPO1 mutation in a real‐life chronic lymphocytic leukaemia cohort

Giulia Tueur , Gregory Lazarian , Virginie Eclache , Carole Fleury , Rémi Letestu et al.
British Journal of Haematology, 2020, 191 (3), pp.e90-e94. ⟨10.1111/bjh.17046⟩
Article dans une revue hal-03942496v1

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Panagiotis Baliakas , Sabine Jeromin , Michalis Iskas , Anna Puiggros , Karla Plevova et al.
Blood, 2019, 133 (11), pp.1205-1216. ⟨10.1182/blood-2018-09-873083⟩
Article dans une revue hal-03946254v1

An Axis Involving beta-Catenin and BTK Controls the Interaction with the Microenvironment in CLL

Souhail Ouriemmi , Tareck Rharass , Grégory Lazarian , Valérie Gratio , Christine Le Roy et al.
5th International Conference New Concepts In Lymphoid Malignancies, Oct 2019, ESTORIL, Portugal
Poster de conférence hal-03944836v1

Down-regulation of CXCR4 and CD62L in Chronic Lymphocytic Leukemia Cells Is Triggered by B-Cell Receptor Ligation and Associated with Progressive Disease

Amalia Vlad , Pierre-Antoine Deglesne , Rémi Letestu , Stéphane Saint-Georges , Nathalie Chevallier et al.
Cancer Research, 2009, 69 (16), pp.6387-6395. ⟨10.1158/0008-5472.can-08-4750⟩
Article dans une revue hal-03945133v1

Démarche théranostique dans la LLC : Quel apport de la recherche des mutations de différents gènes de la voie de p53 par NGS ?

G Tueur , V Eclache , G Lazarian , C Fleury , R Letestu et al.
Congrès de la Société Française d’Hématologie, Mar 2019, PARIS, France
Communication dans un congrès hal-03966314v1

Profil des mutations de TP53 dans la Leucémie Lymphoïde Chronique (LLC) : une étude FILO

F Baran-Marszak , L Véronèse , P Sujobert , A Bidet , F Davi et al.
Congrès de la Société Française d’Hématologie, Sep 2017, PARIS, France
Poster de conférence hal-03968400v1
Image document

A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line.

Inès Souissi , Patrick Ladam , Jean Cognet , Stéphanie Le Coquil , Nadine Varin-Blank et al.
Molecular Cancer, 2012, 11 (1), pp.12. ⟨10.1186/1476-4598-11-12⟩
Article dans une revue inserm-00687513v1

Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma

Sophie Bernard , Damien Danglade , Laura Gardano , Christelle Laguillier , Gregory Lazarian et al.
International Journal of Cancer, 2015, 136 (12), pp.2761-2774. ⟨10.1002/ijc.29326⟩
Article dans une revue hal-03944897v1

Relapse of acquired von Willebrand syndrome in a patient non-compliant with Crohn's disease

Myriam Hormi , Melchior Le Méné , Céline Comparon , Imededdine El Kout , Fanny Baran-Marszak et al.
Autre publication scientifique hal-03893004v1

TP53, XPO1 and ATM Mutations Exclusive Distribution in the Adverse Prognosis Chronic Lymphocytic Leukemia (CLL) Group

Giulia Tueur , Virginie Eclache , Grégory Lazarian , Carole Fleury , Rémi Letestu et al.
Society of Hematological Oncoclogy (SOHO), Nov 2018, Houston (TX), United States. 18, pp.S218, 2018, ⟨10.1016/j.clml.2018.07.084⟩
Poster de conférence hal-03965966v1
Image document

Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma

Gregory Lazarian , Chloe Friedrich , Anne Quinquenel , Julie Tran , Souhail Ouriemmi et al.
Oncogene, 2020, 39 (14), pp.2934-2947. ⟨10.1038/s41388-020-1183-x⟩
Article dans une revue inserm-02534412v1
Image document

Impact of Low-Burden TP53 Mutations in the Management of CLL

Gregory Lazarian , Florence Cymbalista , Fanny Baran-Marszak
Frontiers in Oncology, 2022, 12, ⟨10.3389/fonc.2022.841630⟩
Article dans une revue hal-03942466v1

The AXL tyrosine kinase inhibitor, BGB324, induces cell death in mantle cell lymphoma

P Gelebart , J Han , I Karlsen , M E Gjerstad , L Helgeland et al.
European Hematology Association, Jun 2018, STOCKHLOM, Sweden
Poster de conférence hal-03968396v1

Les mutations de TP53 au codon 234 sont associées au traitement par chlorambucil dans la Leucémie Lymphoïde Chronique

Gregory Lazarian , F Theves , M Hormi , R Letestu , V Eclache et al.
Congrès annuel de la Société Française d’Hématologie, Nov 2022, PARIS, France
Poster de conférence hal-03968447v1

LEUKEMIEA CUTIS IN CHRONIC LYMPHOCYTIC LEUKEMIA: A RETROSPECTIVE STUDY of the French Innovative Leumkemia organization (FILO)

Gregory Lazarian , M Munger , A Quinquenel , M Dilhuydy , L Veronese et al.
EHA, Jun 2021, PARIS, France
Poster de conférence hal-03968460v1

Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

Larry Mansouri , Birna Thorvaldsdottir , Lesley-Ann Sutton , Georgios Karakatsoulis , Manja Meggendorfer et al.
Article dans une revue hal-03942442v1
Image document

Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience

Anne Sophie Alary , Carole Maute , Olivier Kosmider , Pierre Sujobert , Audrey Gauthier et al.
HemaSphere, 2021, 5 (12), pp.e658. ⟨10.1097/hs9.0000000000000658⟩
Article dans une revue hal-03464576v1

Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study

Anne Quinquenel , Luc-Matthieu Fornecker , Remi Letestu , Loic Ysebaert , Carole Fleury et al.
Blood, 2019, 134 (7), pp.641-644. ⟨10.1182/blood.2019000854⟩
Article dans une revue hal-02301308v1

Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression

Arsène Mékinian , Anne Quinquenel , Koceila Ait Belkacem , Fériel Kanoun , Elisabetta Dondi et al.
2022
Pré-publication, Document de travail hal-03966227v1

CLL-240 Frequency of IKZF3 L162R Mutation in B-Cell Lymphoproliferative Disorders

Assia Taleb , Carole Fleury , Florence Cymbalista , Fanny Baran-Marszak , Gregory Lazarian et al.
SOHO, Sep 2022, Houston (Texas), United States. 22, pp.S274, 2022, ⟨10.1016/s2152-2650(22)01338-6⟩
Poster de conférence inserm-03950175v1

Dihydroorotate dehydrogenase inhibition acts synergistically with tyrosine kinase inhibitors to induce apoptosis of mantle cell lymphoma cells

May Eriksen-Gjerstad , Ida Tveit Karlsen , Zinayida Fandalyuk , Susanne Benjaminsen , Fanny Baran-Marszak et al.
EJHaem / eJournal of Haematology, 2022, 3 (3), pp.913-918. ⟨10.1002/jha2.434⟩
Article dans une revue inserm-03950084v1

A primitive plasma cell leukemia with immunoglobulin (Ig) E

Meriem Rachidi , Gregory Lazarian , Rémi Letestu , Daniel Lusina , Cedric Desbene et al.
2019, pp.557-561. ⟨10.1684/abc.2019.1476⟩
Autre publication scientifique hal-03942510v1

Microenvironment education by tumor cells in Chronic Lymphocytic Leukemia: a metabolic and morphological perspective

Jordan Ferreira , Imane Mihoub , Antonin Oudar , Gregory Lazarian , Fanny Baran-Marszak et al.
5th International Cancer Symposium, Nov 2022, LYON, France
Poster de conférence hal-03944870v1

High Prevalence of BTK Mutations on Ibrutinib Therapy after 3 Years of Treatment in a Real-Life Cohort of CLL Patients: A Study from the French Innovative Leukemia Organization (FILO) Group

Anne Quinquenel , Luc Matthieu Fornecker , Remi Letestu , Carole Fleury , Loic Ysebaert et al.
ASH, Nov 2018, New orleans, United States. pp.584-584, ⟨10.1182/blood-2018-99-114027⟩
Communication dans un congrès hal-03965861v1

Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A

C. Kelaidi , T. Braun , R. Arana , A. Marceau-Renaut , G. Lazarian et al.
Leukemia Research, 2018, 71, pp.67-74. ⟨10.1016/j.leukres.2018.05.007⟩
Article dans une revue hal-03966154v1

High Frequency of Mutations in BTK and PLCG2 in Chronic Lymphocytic Leukemia (CLL) Patients on Ibrutinib Therapy

Carole Fleury , Anne Quinquenel , Luc-Matthieu Fornecker , Loïc Ysebaert , Catherine Thieblemont et al.
Society of Hematologic Oncology, Nov 2018, Houston, United States. 18, pp.S217-S218, 2018, ⟨10.1016/j.clml.2018.07.083⟩
Poster de conférence hal-03965956v1

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice

Bernard Leroy , Mandy L Ballinger , Fanny Baran-Marszak , Gareth L Bond , Antony Braithwaite et al.
Cancer Research, 2017, 77 (6), pp.1250-1260. ⟨10.1158/0008-5472.CAN-16-2179⟩
Article dans une revue hal-02343459v1